Skip to main content
Supplement Research and Comparison WebsiteBest Price Guarantee
Supplement Research and Comparison Website

Abstract

In the present study, the effect of Lactic Acid Bacteria (LAB) was investigated at the molecular level using the model organism Caenorhabditis elegans against Klebsiella pneumoniae. Out of the 13 LAB screened, Lactobacillus casei displayed excellent protective efficacy by prolonging the survival of K. pneumoniae-infected nematodes. Pretreatment with L. casei significantly decreased bacterial colonization and rescued K. pneumoniae-infected C. elegans from various physiological impairments. The concomitant upregulation of key immune genes that regulate the TLR, RACK-1 as well as the p38 MAPK pathway rather than the IIS and ERK pathway suggested that the plausible immunomodulatory mechanism of L. casei could be by triggering the TLR, RACK-1 and p38 MAPK pathway. Furthermore, the hyper-susceptibility of L. casei treated loss-of-function mutants of the tol-1, RACK-1 and p38 MAPK pathway (sek-1 and pmk-1) to K. pneumoniae infection and gene expression analysis suggested that L. casei triggered a TLR mediated RACK-1 dependent p38 MAPK pathway to increase host resistance and protect nematodes against K. pneumoniae infection.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus casei PXN 37Enhanced Host ResistanceBeneficial
Large
Lactobacillus casei UALc-03Enhanced Host ResistanceBeneficial
Large
Lactobacillus casei UALc-03Enhanced Resistance to Bacterial InfectionsBeneficial
Large
Lactobacillus casei UALc-03Increased Immune Gene ExpressionBeneficial
Moderate
Lactobacillus casei UALc-03Reduced Helicobacter pylori ColonizationBeneficial
Moderate
Lactobacillus casei VK4Enhanced Resistance to InfectionsBeneficial
Large
Lactobacillus casei VK4Reduced Helicobacter pylori ColonizationBeneficial
Moderate
Lactobacillus casei VK4Reduced Physiological ImpairmentsBeneficial
Large
Back to top